1. Medtech Insight
  2. >>Device Area

Start-Up Spotlight: Enable Injections, On-Body Biologics Delivery By Oreo-Sized Device

 
• By Bob Kronemyer

Enable Injections has developed a small wearable device that allows controlled delivery of biologic drugs – of small to potentially large volumes – while the patient continues with their daily life.

Instead of enduring costly, repeated intravenous infusions of medicine for chronic diseases in a health-care setting, patients could eventually be equipped with a wearable injector for the delivery of a biologic drug at a controlled flow rate.

A small, low-profile, on-body delivery system from Enable Injections Inc. is roughly the size of an Oreo cookie and will be available in six drug volume sizes, ranging from 5ml-50 ml

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Combination Products

More from Device Area

Consumer Healthtech Investment Totaled $4.5BN In 2024, But Bar Is High Amid Economic Uncertainty

 
• By Marion Webb

Global investment in consumer healthtech increased by 9% year-over-year in 2024, totaling $4.5bn, with significant interest in mental health solutions, according to Galen Growth. While the first quarter of 2025 saw raised confidence and investments, the Trump administration’s new tariffs and sweeping changes to healthcare have introduced new uncertainties.

FDA And Boston Scientific Face Legal Action Over Spinal Device Safety

 
• By Elizabeth Orr

A patient, Dena Lawler, is suing Boston Scientific and the US FDA over alleged harm from a spinal stimulator device. Lawler claims inadequate regulatory review allowed dangerous modifications to the device, which then caused her pain and other health issues. She is calling for reconsideration of the device approvals.

California Medtech Firms Resolve Patent Dispute Over Delivery Catheters

 
• By Brian Bossetta

Route 92 says it has reached a settlement with Q’Apel Medical over patent claims concerning its Tenzing delivery catheters.